Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
8.23
+0.03 (0.37%)
Oct 31, 2025, 1:38 PM EDT - Market open
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $50.63 million as of October 31, 2025. Its market cap has increased by 117.88% in one year.
Market Cap
50.63M
Enterprise Value
-66.24M
1-Year Change
117.88%
Ranking
Category
Stock Price
$8.23
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $50.63M, a decrease of -90.85%. That is a compound annual growth rate of -37.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 50.44M | -65.89% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |